Skip to main content
Erschienen in: Journal of Clinical Monitoring and Computing 4/2021

20.05.2020 | Original Research

Hyperlactatemia in diabetic ketoacidosis is common and can be prolonged: lactate time-series from 25 intensive care admissions

verfasst von: Thomas J. Morgan, Peter H. Scott, Christopher M. Anstey, Francis G. Bowling

Erschienen in: Journal of Clinical Monitoring and Computing | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Hyperlactatemia is a documented complication of diabetic ketoacidosis (DKA). Lactate responses during DKA treatment have not been studied and were the focus of this investigation. Blood gas and electrolyte data from 25 DKA admissions to ICU were sequenced over 24 h from the first Emergency Department sample. Hyperlactatemia (> 2 mmol/L) was present in 22 of 25 DKA presentations [mean concentration = 3.2 mmol/L]. In 18 time-series (72%), all concentrations normalized in ≤ 2.6 h (aggregate decay t1/2 = 2.29 h). In the remaining 7 (28%), hyperlactatemia persisted > 12 h. These were females (P = 0.04) with relative anemia (hemoglobin concentrations 131 v 155 g/L; P = 0.004) and lower nadir glucose concentrations (5.2 v 8.0 mmol/L, P = 0.003). Their aggregate glucose decay curve commenced higher (42 mmol/L v 29 mmol/L), descending towards a lower asymptote (8 mmol/L v 11 mmol/L). Tonicity decay showed similar disparities. There was equivalent resolution of metabolic acidosis and similar lengths of stay in both groups. Hyperlactatemia is common in DKA. Resolution is often rapid, but high lactates can persist. Females with high glucose concentrations corrected aggressively are more at risk. Limiting initial hyperglycemia correction to ≥ 11 mmol/L may benefit.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
8.
Zurück zum Zitat Morgan TJ, Scott PJ, Anstey CM. Rapid haemodilution accelerates hypertonicity resolution in diabetic ketoacidosis: data from 25 intensive care admissions. Crit Care Resusc. 2019;21(4):274–83.PubMed Morgan TJ, Scott PJ, Anstey CM. Rapid haemodilution accelerates hypertonicity resolution in diabetic ketoacidosis: data from 25 intensive care admissions. Crit Care Resusc. 2019;21(4):274–83.PubMed
13.
Zurück zum Zitat Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.CrossRef Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.CrossRef
15.
Zurück zum Zitat Siggaard-Andersen O, Fogh-Andersen N. Base excess or buffer base (strong ion difference) as measure of a non-respiratory acid-base disturbance. Acta Anaesthesiol Scand Suppl. 1995;107:123–8.CrossRef Siggaard-Andersen O, Fogh-Andersen N. Base excess or buffer base (strong ion difference) as measure of a non-respiratory acid-base disturbance. Acta Anaesthesiol Scand Suppl. 1995;107:123–8.CrossRef
16.
Zurück zum Zitat Bhagat CI, Garcia-Webb P, Fletcher E, Beilby JP. Calculated vs measured plasma osmolalities revisited. Clin Chem. 1984;30(10):1703–5.CrossRef Bhagat CI, Garcia-Webb P, Fletcher E, Beilby JP. Calculated vs measured plasma osmolalities revisited. Clin Chem. 1984;30(10):1703–5.CrossRef
18.
Zurück zum Zitat Kitabchi A, Hirsch, IB, Emmett, M (2015) Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: clinical features, evaluation and diagnosis. UpToDate. Accessed 20 Jan 2016 Kitabchi A, Hirsch, IB, Emmett, M (2015) Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: clinical features, evaluation and diagnosis. UpToDate. Accessed 20 Jan 2016
20.
Zurück zum Zitat Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–29.CrossRef Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–29.CrossRef
21.
Zurück zum Zitat Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100(6):1619–36.CrossRef Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100(6):1619–36.CrossRef
22.
Zurück zum Zitat Paul E, Bailey M, Kasza J, Pilcher D. The ANZROD model: better benchmarking of ICU outcomes and detection of outliers. Crit Care Resusc. 2016;18(1):25–36.PubMed Paul E, Bailey M, Kasza J, Pilcher D. The ANZROD model: better benchmarking of ICU outcomes and detection of outliers. Crit Care Resusc. 2016;18(1):25–36.PubMed
24.
Zurück zum Zitat Bolli G, Cartechini MG, Compagnucci P, Massi-Benedetti M, Filipponi P, Nicoletti I, De Feo P, Angeletti G. Adrenergic activity and glycometabolic compensation in patients with diabetes mellitus. Minerva Med. 1979;70(55):3783–95.PubMed Bolli G, Cartechini MG, Compagnucci P, Massi-Benedetti M, Filipponi P, Nicoletti I, De Feo P, Angeletti G. Adrenergic activity and glycometabolic compensation in patients with diabetes mellitus. Minerva Med. 1979;70(55):3783–95.PubMed
25.
Zurück zum Zitat Morgan TJ, Venkatesh B, Bellomo R. Acid-base physiology: comments on 10 contentious assertions. Crit Care Resusc. 2015;17(3):211–3.PubMed Morgan TJ, Venkatesh B, Bellomo R. Acid-base physiology: comments on 10 contentious assertions. Crit Care Resusc. 2015;17(3):211–3.PubMed
29.
Zurück zum Zitat Bender DA, Mayes PA. Overview of metabolism & the provision of metabolic fuels. In: Rodwell VW, Bender DA, Botham KM, Kennelly PJ, Weil PA, editors. Harper's Illustrated Biochemistry. New York: McGraw-Hill Education; 2018. Bender DA, Mayes PA. Overview of metabolism & the provision of metabolic fuels. In: Rodwell VW, Bender DA, Botham KM, Kennelly PJ, Weil PA, editors. Harper's Illustrated Biochemistry. New York: McGraw-Hill Education; 2018.
30.
Zurück zum Zitat Botham KM, Mayes PA. Biosynthesis of fatty acids & eicosanoids. In: Rodwell VW, Bender DA, Botham KM, Kennelly PJ, Weil PA, editors. Harper's Illustrated Biochemistry. New York: McGraw-Hill Education; 2018. Botham KM, Mayes PA. Biosynthesis of fatty acids & eicosanoids. In: Rodwell VW, Bender DA, Botham KM, Kennelly PJ, Weil PA, editors. Harper's Illustrated Biochemistry. New York: McGraw-Hill Education; 2018.
40.
Zurück zum Zitat Faigel DO, Metz DC. Prevalence, etiology, and prognostic significance of upper gastrointestinal hemorrhage in diabetic ketoacidosis. Dig Dis Sci. 1996;41(1):1–8.CrossRef Faigel DO, Metz DC. Prevalence, etiology, and prognostic significance of upper gastrointestinal hemorrhage in diabetic ketoacidosis. Dig Dis Sci. 1996;41(1):1–8.CrossRef
41.
Zurück zum Zitat Martensson J, Bailey M, Venkatesh B, Pilcher D, Deane A, Abdelhamid YA, Crisman M, Verma B, MacIsaac C, Wigmore G, Shehabi Y, Suzuki T, French C, Orford N, Kakho N, Prins J, Ekinci EI, Bellomo R. Intensity of early correction of hyperglycaemia and outcome of critically ill patients with diabetic ketoacidosis. Crit Care Resusc. 2017;19(3):266–73.PubMed Martensson J, Bailey M, Venkatesh B, Pilcher D, Deane A, Abdelhamid YA, Crisman M, Verma B, MacIsaac C, Wigmore G, Shehabi Y, Suzuki T, French C, Orford N, Kakho N, Prins J, Ekinci EI, Bellomo R. Intensity of early correction of hyperglycaemia and outcome of critically ill patients with diabetic ketoacidosis. Crit Care Resusc. 2017;19(3):266–73.PubMed
43.
Zurück zum Zitat Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–77. https://doi.org/10.1007/s00134-017-4683-6.CrossRefPubMed Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–77. https://​doi.​org/​10.​1007/​s00134-017-4683-6.CrossRefPubMed
Metadaten
Titel
Hyperlactatemia in diabetic ketoacidosis is common and can be prolonged: lactate time-series from 25 intensive care admissions
verfasst von
Thomas J. Morgan
Peter H. Scott
Christopher M. Anstey
Francis G. Bowling
Publikationsdatum
20.05.2020
Verlag
Springer Netherlands
Erschienen in
Journal of Clinical Monitoring and Computing / Ausgabe 4/2021
Print ISSN: 1387-1307
Elektronische ISSN: 1573-2614
DOI
https://doi.org/10.1007/s10877-020-00532-9

Weitere Artikel der Ausgabe 4/2021

Journal of Clinical Monitoring and Computing 4/2021 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.